Global asset manager Rithm Capital Corp. RITM is set to report fourth-quarter 2024 results on Feb. 6, 2025, before the ...

T. Rowe Price Group noted improvements in earnings year over year, yet missed analysts' expectations for both EPS and revenue due to sizable net client outflows.

Despite significant dips in its vaccines sales, the British pharma narrowly beat consensus estimates for Q4 2024 and raised ...

The year for McDonald’s began as the brand hinted it would—with we hadn’t seen in nearly six calendars. The McValue platform, ...

The Mondelez marketer is the first in the snack category to take advantage of Sponsored Snaps, which include a link to make a purchase.

Total subscribers: 11.43 million at the end of Q4, up 10.3% from the 10.36 million subscribers the year prior and 3% from Q3 2024. As usual, the vast majority of those subscribers — 10.82 million — ...

Uber tumbled early Wednesday after Q4 earnings and sales beat but its bookings target came in light.

If there were any fears that spending on AI infrastructure was about to slow down, that was put to rest when Trump announced ...

Reports Q4 revenue $12B, consensus $11.77B. Gross Bookings grew 18% year-over-year and 21% year-over-year on a constant currency basis. “Uber ...

Santander Brasil's NII - earnings on loans minus deposit costs - rose 16% in the fourth quarter to 15.98 billion reais, while ...

After falling behind Taiwan Semiconductor Manufacturing (NYSE: TSM) in process technology, Intel embarked on an ambitious and ...

Robert F. Kennedy Jr.’s HHS nomination moves to a full Senate vote; Donald Trump’s tariff war sparks China-related concerns for biopharma; Pfizer, Merck and more announce Q4 and 2024 earnings; and the ...